
AUPH
Healthcare · Biotechnology · $2.11B market cap
$15.73-0.48 (-3.0%)Nov 13, 4:00 PM EST
Next report
Before the open
Analyst consensus
Fiscal period ending Dec 31, 2026
EPS trend, 90 days to now · -5.3% over 90 days · 30-day revisions 2 up, 2 down
Beat estimates in 4 of the last 4 reported quarters.
EPS surprise versus the estimate at the time of the report.
| Date | Session | Estimate | Actual | Surprise |
|---|---|---|---|---|
| Mar 1, 2027 · upcoming | Before the open | 0.21 | — | — |
| Oct 30, 2026 | Before the open | 0.20 | 0.23 | +15.0% |
| Aug 6, 2026 | Before the open | 0.18 | 0.28 | +55.6% |
| Apr 30, 2026 | Time not confirmed | 0.16 | 0.25 | +56.3% |
| Feb 26, 2026 | Before the open | 0.21 | 0.26 | +23.8% |
| Nov 4, 2025 | Before the open | 0.16 | 0.23 | +43.8% |
| Jul 31, 2025 | Before the open | 0.15 | 0.16 | +6.7% |
| May 12, 2025 | Before the open | 0.10 | 0.16 | +60.0% |
| Feb 13, 2025 | Before the open | -0.02 | 0.01 | +162.5% |
| Nov 7, 2024 | Before the open | 0.02 | 0.10 | +400.0% |
| Aug 1, 2024 | Before the open | 0.01 | 0.01 | 0.0% |
| May 2, 2024 | Before the open | -0.14 | -0.07 | +50.0% |
| Feb 15, 2024 | Before the open | -0.16 | -0.19 |
Aurinia Pharmaceuticals Inc., a biopharmaceutical company, engages in delivering therapies to people living with autoimmune diseases with high unmet medical needs in the United States and Japan. The company offers LUPKYNIS (voclosporin), an oral therapy for the treatment of adult patients with active lupus nephritis. It also develops aritinercept, a dual inhibitor of B cell-activating factor and…
| -18.8% |
| Nov 2, 2023 | Before the open | -0.17 | -0.09 | +47.1% |
| Aug 3, 2023 | Before the open | -0.19 | -0.08 | +57.9% |
| May 4, 2023 | Before the open | -0.22 | -0.18 | +18.2% |
| Feb 28, 2023 | Before the open | -0.27 | -0.18 | +33.3% |
| Nov 3, 2022 | Before the open | -0.19 | -0.06 | +68.4% |
| Aug 4, 2022 | Before the open | -0.22 | -0.25 | -13.6% |
| May 10, 2022 | Before the open | -0.27 | -0.27 | 0.0% |
| Feb 28, 2022 | Before the open | -0.27 | -0.25 | +7.4% |
| Nov 3, 2021 | Before the open | -0.33 | -0.39 | -18.2% |
| Aug 5, 2021 | After the close | -0.36 | -0.37 | -2.8% |
| May 6, 2021 | After the close | -0.38 | -0.40 | -5.3% |
| Feb 24, 2021 | Before the open | -0.24 | -0.05 | +79.2% |
| Nov 10, 2020 | After the close | -0.24 | -0.30 | -25.0% |
| Aug 11, 2020 | After the close | -0.24 | -0.26 | -8.3% |
| May 14, 2020 | After the close | -0.34 | -0.23 | +32.4% |
| Mar 5, 2020 | After the close | -0.21 | -0.78 | -271.4% |
| Nov 14, 2019 | After the close | -0.18 | -0.21 | -16.7% |
| Aug 6, 2019 | After the close | -0.17 | -0.17 | 0.0% |
| May 14, 2019 | After the close | -0.18 | -0.16 | +11.1% |
| Mar 19, 2019 | After the close | -0.18 | -0.17 | +5.6% |
| Nov 8, 2018 | After the close | -0.19 | -0.21 | -10.5% |
| Aug 9, 2018 | After the close | -0.17 | -0.16 | +5.9% |
| May 10, 2018 | After the close | -0.17 | -0.15 | +11.8% |
| Mar 15, 2018 | After the close | -0.14 | -0.04 | +71.4% |